Radiotherapy-associated anemia: The scope of the problem

Oncologist

Volumn 5, Issue SUPPL. 2, 2000, Pages 1-7

  Harrison, Louis B ^a   Shasha, Daniel ^a   White, Carol ^a   Ramdeen, Beverly ^a  

^a BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

Anemia; Locoregional control; Quality of life; Radiotherapy; Tumor hypoxia

Indexed keywords

ANEMIA; CANCER; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONFERENCE PAPER; HUMAN; PRIORITY JOURNAL; QUALITY OF LIFE;

EID: 0034126527     PISSN: 10837159     EISSN: None     Source Type: Journal    
DOI: 10.1634/theoncologist.5-suppl_2-1     Document Type: Conference Paper

References (17)

1. Cella D. Factors influencing quality of life in cancer patients: anemia and fatigue. Semin Oncol 1998;25:43-46.
2. Grogan M, Thomas GM, Melamed I et al. The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix. Cancer 1999;86:1528-1536.
3. Lee WR, Berkey B, Marcial V et al. Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: a secondary analysis of RTOG 85-27. Int J Radiat Oncol Biol Phys 1998;42:1069-1075.
4. Vogelzang NJ, Breitbart W, Cella D et al. Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. Int J Radiat Oncol Biol Phys 1997;34:4-12.
5. Hollaender A, Stapleton GE, Martin FL. X-ray sensitivity of E. coli as modified by oxygen tension. Nature 1951;167:103-104.
6. Fleming ID, Brady LW, Mieszkalski GB et al. Basis for major current therapies for cancer. In: Murphy GP, Lawrence W, Lenhard RE, eds. American Cancer Society Textbook of Clinical Oncology. Atlanta: American Cancer Society, 1995:96-134.
7. Fyles AW, Milosevic M, Wong R et al. Oxygenation predicts radiation response and survival in patients with cervix cancer. Radiother Oncol 1998;48:149-156.
8. Bush RS. The significance of anemia in clinical radiation therapy. Int J Radiat Oncol Biol Phys 1986;12:2047-2050.
9. Fein DA, Lee R, Hanlon AL et al. Pretreatment hemoglobin level influences local control and survival of T1-T2 squamous cell carcinomas of the glottic larynx. J Clin Oncol 1995;13:2077-2083.
10. Warde P, O'Sullivan B, Bristow RG et al. T1/T2 glottic cancer managed by external beam radiotherapy: the influence of pretreatment hemoglobin on local control. Int J Radiat Oncol Biol Phys 1998;41:347-353.
11. Girinski T, Pejovic-Lenfant MH, Bourhis J et al. Prognostic value of hemoglobin concentrations and blood transfusions in advanced carcinoma of the cervix treated by radiation therapy: results of a retrospective study of 386 patients. Int J Radiat Oncol Biol Phys 1989;16:37-42.
12. Haffty BG, Son YH. Papac R et al. Chemotherapy as an adjunct to radiation in the treatment of squamous cell carcinoma of the head and neck: results of the Yale Mitomycin Randomized Trials. J Clin Oncol 1997;15:268-276.
13. Martinez J, Cabezon M, Fuentes C et al. Hyperfractionated chemoradiotherapy with carbogen breathing for advanced head and neck cancer. Int J Radiat Oncol Biol Phys 1999:45(suppl):377.
14. Curt GA, Breitbart W, Cella DF et al. Impact of cancer-related fatigue on the lives of patients. Proc Am Soc Clin Oncol 1999;18:573A.
15. Demetri GD, Kris M, Wade J et al. Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. J Clin Oncol 1998;16:3412-3425.
16. Glaspy J, Bukowski R, Steinberg D et al. Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. J Clin Oncol 1997;15:1218-1234.
17. Dubray B, Mosseri V, Brunin F et al. Anemia is associated with lower local-regional control and survival after radiation therapy for head and neck cancer: a prospective study. Radiology 1996;201:553-558.